CLEVELAND, Feb. 28, 2022 /PRNewswire/ -- MIM Software Inc. announced today a partnership with leading global provider of integrated cancer care, GenesisCare, to increase patient access to world-class care on a global scale. GenesisCare's clinical teams treat more than 400,000 patients at more than 440 locations for cancer treatment in the United States, Australia, United Kingdom, and Spain.
The strategic partnership between GenesisCare and MIM Software was created with the sole focus of improving cancer patient outcomes by augmenting the Radiation Oncology and Molecular Therapy treatment planning ecosystem.
The partnership between GenesisCare and MIM Software was created with the focus of improving cancer patient outcomes.
Ad Statistics
Times Displayed: 49670
Times Visited: 1409 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
"Our partnership with GenesisCare exemplifies MIM Software's commitment to delivering scalable technologies and solutions that can support, sustain, and impact patients' lives on a global scale," said Andy Nelson, CEO of MIM Software.
MIM Software will supply, implement, and support MIM Premier®, MIM SurePlan™ MRT, and a comprehensive set of automation and AI platforms across all of GenesisCare's global treatment centers. The partnership leans on GenesisCare's vision of optimizing and automating treatment delivery to a high level, for which it will leverage MIM Software's expertise and world-class imaging technologies to drive data empowered decisions.
"Providing a technology uplift on such a scale opens the door to continuous access to collaborative innovations that patients can benefit from almost instantaneously, regardless of where they are geographically located," said Kanak Chatterjee, Vice President of Business Development at MIM Software.
"We are delighted to expand our partnership with MIM Software, building on the strong foundations and success with the solution in our clinics in Australia and Europe," said Keith Hansen, Chief Strategy & Corporate Development Officer at GenesisCare.
"Over the past 18 months, we have invested significant time and capital in upgrading and installing innovative treatment technologies in our centers across the United States, Australia, United Kingdom, and Spain, so that our patients can access world-class cancer care at their doorstep. By implementing MIM Software into our clinics, we will be able to fully realize the benefits of these advanced technologies and provide highly advanced stereotactic treatment techniques that deliver the best possible outcomes for our patients."
